ATAD2 and ovarian cancer: Analysis of patient-derived ovarian cancer samples revealed higher ATAD2 expression in metastatic ovarian cancer samples than in primary-site samples; therefore, we asked whether ATAD2 is necessary for the development of metastatic properties in ovarian cancer.